Lentiviral Vector Market Size, Trends and Forecast 2024-2032

According to FutureWise analysis the market for lentiviral vector in 2023 was US$ 176.8 million, and is expected to reach US$ 690 million by 2031 at a CAGR of 17.6%.

Lentiviral vectors (LV) are effective vehicles for gene transfer in mammalian cells due to their ability to stably express a gene of interest in both non-dividing and dividing cells. Pathogens known as lentiviruses affect both humans and animals and have protracted incubation times. The interval between the first infection and the onset of the first symptoms can be many months or even several years. To introduce genetic material into cells, molecular scientists typically use viral vectors. The operation can be carried out (in vitro) as well as In vivo (within a living creature) or in cell culture. For effective genome transfer inside the infected cells, viruses have developed specialised molecular pathways.

Over the past two decades, lentiviral vectors, which are derived from the human immunodeficiency virus, have been thoroughly studied and improved. Recent clinical trials have used third-generation, self-inactivating lentiviral vectors to insert genes into hematopoietic stem cells to treat primary immunodeficiencies and hemoglobinopathies. The development of gene-modified cell therapies, particularly T-cell therapies, has been greatly aided by lentiviral vectors. Examples of T cell treatments that are currently commercially accessible for distribution after successfully getting EMA and FDA authorisation for the treatment of blood malignancies include tisagenlecleucel (Kymriah), axicabtagene ciloleucel (Yescarta) and, most recently brexucabtagene autoleucel (Tecartus). The therapeutic chimeric antigen receptor (CAR) is transduced into T cells in all three treatments using retroviral vectors.

FutureWise Market Research has published a report that provides an insightful analysis of lentiviral vector market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Lentiviral-Vector-Market/14631

Lentiviral Vector Market Segmentation: